- Full Year 2023 Transgene SA Earnings Call TranscriptMar 27, 2024€1.08 (-0.55%)Earnings
- Half Year 2023 Transgene SA Earnings Call TranscriptSep 20, 2023€1.81 (+1.80%)Earnings
- Transgene SA Conference Call TranscriptMay 05, 2023
- Full Year 2022 Transgene SA Earnings Call TranscriptMar 16, 2023€1.91 (-1.55%)Earnings
- Transgene SA Interim Analysis of TG4001 Phase II Trial Call TranscriptNov 02, 2022
- Transgene SA R&D Day TranscriptSep 27, 2022
- Q2 2022 Transgene SA Earnings Call TranscriptSep 07, 2022€2.06 (+0.49%)Earnings
- Q4 2021 Transgene SA Earnings Call TranscriptMar 16, 2022€2.22 (+6.47%)Earnings
- Transgene SA Corporate Call TranscriptDec 15, 2021
- Transgene SA TG4050 Phase I Studies Results Webcast TranscriptNov 23, 2021
- Q2 2021 Transgene SA Earnings Call TranscriptSep 22, 2021€2.41 (+1.26%)Earnings
- Transgene SA Presents Results From the Phase 1b/2 trial of TG4001 in Combination with Avelumab Conference Call TranscriptNov 12, 2020
- Transgene SA Results from Clinical Study of TG4001 in Combination with Avelumab Conference Call TranscriptJul 22, 2020
- Q4 2019 Transgene SA Earnings Call TranscriptMar 11, 2020€1.23 (+6.59%)Earnings
Transgene SA Presents Results From the Phase 1b/2 trial of TG4001 in Combination with Avelumab Conference Call Transcript
Hello, and welcome to the presentation of the Phase Ib/II data of TG4001 plus avelumab in HPV16-positive cancers. My name is Jess, and I'll be your coordinator for today's event. (Operator Instructions)
I will now hand you over to your host, Lucie Larguier, to begin today's call. Thank you.
Thank you, Jess. Hello, everyone. I'm Lucie Larguier. Today with me are Philippe Archinard and Maud Brandely. And we are very excited to provide you with more details on the results we obtained with TG4001 in combination with avelumab in our Phase Ib/II trial.
Before I turn the call over to Mr. Archinard, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to a number of risks and uncertainties. The presentation and the webcast can be accessed via the home page of our website and also on our Investor page. If you are listening to this webcast via Internet, you will not be able to ask questions. (Operator Instructions)
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)